Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Apcotex Industries Limited (APCOTEXIND.NS)
Mumbai, IN
Headquartered in Mumbai, India, Apcotex Industries Limited is a prominent producer and supplier of synthetic emulsion polymers. Founded in 1980, the company operated as Apcotex Lattices Limited until its rebranding in 2005. Its extensive product range encompasses various synthetic latexes, including carboxylated styrene butadiene, styrene acrylic, vinyl pyridine, and nitrile latexes, which are integral to applications like tire cord dipping, paper and paperboard coatings, carpet backing, concrete modification, waterproofing, non-wovens, textile finishing, paints, and gloves. Furthermore, Apcotex manufactures synthetic rubber products such as nitrile, NBR polyblend and powder, and high styrene rubber, serving critical uses in footwear, automotive components, rice rollers, molded items, V-belts, and conveyor belts. The company also actively exports its offerings to global markets.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.99% | -11.67% | +26.19% | +26.84% | +17.87% | +27.44% | +44.17% | -0.75% | +53.35% | +312.99% | +11,534.15% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+3.5% Q1'26: +13.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+87.5% ★ Q1'26: +107.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+9.4% ★ Q1'26: +21.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+8.9% ★ Q1'26: +10.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+14.8% ★ Q1'26: +19.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.54× ★ Q1'26: 0.44× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.53B
est: 3.65B (-3.2%)
|
2.95B
est: 3.11B (-5.3%)
|
3.89B
est: 3.70B (+5.1%)
|
5.24B
est: 5.25B (-0.2%)
|
6.23B
est: 6.44B (-3.2%)
|
4.92B
est: 4.98B (-1.2%)
|
5.38B
est: 5.09B (+5.7%)
|
9.51B
est: 9.90B (-3.9%)
|
10.69B
est: 10.51B (+1.7%)
|
11.13B
est: 11.06B (+0.6%)
|
13.92B
est: 14.24B (-2.2%)
|
13.87B
13.87B – 13.87B
-2.6% YoY
|
17.85B
17.85B – 17.85B
+28.7% YoY
|
20.59B
20.59B – 20.59B
+15.3% YoY
|
| EBITDA |
478.11M
est: 473.36M (+1.0%)
|
483.21M
est: 331.55M (+45.7%)
|
593.05M
est: 623.28M (-4.8%)
|
692.68M
est: 1.03B (-32.9%)
|
750.19M
est: 895.97M (-16.3%)
|
390.37M
est: 621.52M (-37.2%)
|
747.81M
est: 356.12M (+110.0%)
|
1.48B
est: 464.25M (+218.2%)
|
1.66B
est: 592.57M (+179.8%)
|
1.22B
est: 810.36M (+50.1%)
|
1.25B
est: 1.80B (-30.7%)
|
1.75B
1.75B – 1.75B
-2.6% YoY
|
2.26B
2.26B – 2.26B
+28.7% YoY
|
2.60B
2.60B – 2.60B
+15.3% YoY
|
| EBIT |
379.80M
est: 389.96M (-2.6%)
|
389.25M
est: 265.09M (+46.8%)
|
460.98M
est: 385.16M (+19.7%)
|
571.25M
est: 213.47M (+167.6%)
|
632.26M
est: 627.18M (+0.8%)
|
256.40M
est: 445.50M (-42.4%)
|
602.69M
est: 172.97M (+248.4%)
|
1.33B
est: 225.50M (+490.8%)
|
1.51B
est: 287.82M (+423.1%)
|
901.32M
est: 393.61M (+129.0%)
|
831.87M
est: 1.45B (-42.8%)
|
1.42B
1.42B – 1.42B
-2.6% YoY
|
1.82B
1.82B – 1.82B
+28.7% YoY
|
2.10B
2.10B – 2.10B
+15.3% YoY
|
| Net Income |
246.81M
est: 250.11M (-1.3%)
|
385.31M
est: 201.28M (+91.4%)
|
349.85M
est: 327.85M (+6.7%)
|
386.36M
est: 440.03M (-12.2%)
|
466.05M
est: 473.65M (-1.6%)
|
166.27M
est: 369.21M (-55.0%)
|
441.59M
est: 143.43M (+207.9%)
|
988.06M
est: 186.98M (+428.4%)
|
1.08B
est: 238.66M (+352.3%)
|
538.79M
est: 326.38M (+65.1%)
|
540.65M
est: 736.21M (-26.6%)
|
917.67M
917.67M – 917.67M
+24.6% YoY
|
1.36B
1.36B – 1.36B
+48.0% YoY
|
1.45B
1.45B – 1.45B
+6.9% YoY
|
| SGA |
136.15M
est: 179.39M (-24.1%)
|
122.47M
est: 115.01M (+6.5%)
|
140.34M
est: 556.14M (-74.8%)
|
165.18M
est: 603.33M (-72.6%)
|
190.08M
est: 672.15M (-71.7%)
|
203.63M
est: 479.41M (-57.5%)
|
271.34M
est: 418.34M (-35.1%)
|
457.55M
est: 545.37M (-16.1%)
|
466.75M
est: 696.10M (-32.9%)
|
555.97M
est: 951.95M (-41.6%)
|
745.05M
est: 906.93M (-17.8%)
|
883.40M
883.40M – 883.40M
-2.6% YoY
|
1.14B
1.14B – 1.14B
+28.7% YoY
|
1.31B
1.31B – 1.31B
+15.3% YoY
|
| EPS |
4.76
est: 4.83 (-1.3%)
|
4.76
est: 4.36 (+9.2%)
|
6.75
est: 4.78 (+41.2%)
|
7.45
est: 8.94 (-16.6%)
|
8.99
est: 9.52 (-5.6%)
|
3.21
est: 6.00 (-46.5%)
|
8.52
est: 6.80 (+25.3%)
|
19.06
est: 18.30 (+4.2%)
|
20.82
est: 23.70 (-12.2%)
|
10.39
est: 14.00 (-25.8%)
|
10.43
est: 14.20 (-26.5%)
|
17.70
17.70 – 17.70
+24.6% YoY
|
26.20
26.20 – 26.20
+48.0% YoY
|
28.00
28.00 – 28.00
+6.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Abhiraj Atul Choksey | Vice Chairman & MD | 24M | male |
| Ravishankar Lakshmanam Sharma | Chief Operating Officer & Executive Director | 10M | male |
| Drigesh Mittal | Head of Legal, Company Secretary & Compliance Officer | — | male |
| Suraj S. Badale | DGM of Accounts | — | male |
| Vivek V. Thakur | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for APCOTEXIND.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
